Certified by Founder Lodge
Monograph Capital
United Kingdom - London
INVESTOR
1 Disclosed Funding Rounds $16,000,000
5 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
With offices in London and San Francisco, Monograph bridges opportunities across North America and the UK/Europe, bringing deep experience, assets and capabilities to help life sciences compa
| Company | Date | Round | Raised |
|---|---|---|---|
 Maxion Therapeutics |
February, 21 ,2023 | Series A | $16,000,000 |
 Ascend Gene & Cell Therapies |
May, 10 ,2023 | Series A | $132,500,000 |
 Sudo Biosciences |
December, 21 ,2023 | Series B | $116,000,000 |
 Nocion Therapeutics, Inc. |
March, 06 ,2024 | Series B | $62,000,000 |
 Elevara Medicines |
October, 24 ,2025 | Series A | $70,000,000 |
Cherry Ventures
Blue Bear Capital
Slow Ventures
Climate Capital
Eniac Ventures
Katalist | $1,500,000 | (Dec 19, 2025)
Amphix Bio | $12,500,000 | (Dec 19, 2025)
Neural Concept | $100,000,000 | (Dec 19, 2025)
Gravity Labs Co., Ltd. | $17,000,000 | (Dec 19, 2025)
arcads AI | $16,000,000 | (Dec 19, 2025)
